Mishima, Japan

Kohei Ogawa

This inventor holds 9 USPTO granted patents and 1 EPO patent. Top assignees: Asahi Kasei Kogyo Kabushiki Kaisha, Asahi Kasei Pharma Corporation, Asahi Pharma Corporation. Active years: 2000-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohei Ogawa. Retrieved from https://idiyas.com/inventor/kohei-ogawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 44.4


Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 54(Granted Patents)


Location History:

  • Shizuoka, JP (2000 - 2006)
  • Mishima, JP (2001 - 2009)

Company Filing History:


Years Active: 2000-2009

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Kohei Ogawa: Pharmaceutical Inventor

Introduction

Kohei Ogawa is an inventor associated with Mishima, Japan. His work includes patent inventions involving indazole compounds described as β3-adrenoceptor agonists. The provided information credits him with 9 patents.

Latest Patents

The listed patent titles are “Indazole Compounds as B3 Adrenoceptor Agonist” and “Indazole Compounds as β3 Adrenoceptor Agonist.” Both descriptions concern compounds of a general formula, or their salts, with specified substituents and structural features, including asymmetric carbon atoms. The compounds are presented as β3-adrenoceptor agonists.

Career Highlights

Ogawa’s listed company affiliations include Asahi Kasei Pharma Corporation and Asahi Kasei Kogyo Kabushiki Kaisha. His patent record, as provided, includes 9 patents.

Collaborations

The listed coworkers are Shiro Miyoshi and Shunichi Ikuta.

Conclusion

Kohei Ogawa’s patent work includes indazole compounds described as β3-adrenoceptor agonists, alongside company affiliations and collaborations in Japan’s pharmaceutical and chemical industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…